Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2001JNCI Journal of the National Cancer InstituteOpen Access

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

View Full Paper
Ask AI
Bookmark
Share

Authors

FJF. JänickeUniversität HamburgAPA. PrechtlKlinikum rechts der IsarCTChristoph ThomssenGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jänicke et al. (2001) studied this question.

synapsesocial.com/papers/6a1be6656f692abb725ef5d8https://doi.org/10.1093/jnci/93.12.913
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonparametric Estimation from Incomplete Observations1958 · 7,786 citations
  2. 2Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast Cancer1992 · 283 citations
  3. 3Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers1996 · 758 citations
  4. 4Prognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer1993 · 257 citations
  5. 5Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials1995 · 1,017 citations